Editorial: Strengths and Challenges of Allo-SCT in the Modern Era

Front Oncol. 2022 Feb 24:12:850403. doi: 10.3389/fonc.2022.850403. eCollection 2022.

¹ Unit of Blood Diseases and Stem Cell Transplantation, ASST-Spedali Civili di Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
² Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
³ Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy.
⁴ Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States.
⁵ Department of Hematology and Cellular Therapy, "Saint Antoine Hospital" AP-HP, Paris, France.

No abstract available

Keywords: CART; allogeneic SCT; cytomegalovirus (CMV); immune reconstitution; relapse prevention.

Publication types